- Investing Ideas
- Swedish Pharmaceuticals & Biotech Healthy high growth potential
Swedish Pharmaceuticals & Biotech Healthy high growth potential
Results
9
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
9 companies
Camurus
Market Cap: SEK 37.2b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 624.50
7D
1.1%
1Y
-10.5%
Bonesupport Holding
Market Cap: SEK 15.0b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 218.60
7D
-2.2%
1Y
-26.1%
BioArctic
Market Cap: SEK 29.8b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 335.60
7D
5.0%
1Y
39.1%
Ascelia Pharma
Market Cap: SEK 81.5m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 0.61
7D
6.1%
1Y
-87.0%
Genovis AB (publ.)
Market Cap: SEK 1.4b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 20.10
7D
2.6%
1Y
-16.3%
Egetis Therapeutics
Market Cap: SEK 3.4b
A pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally.
EGTX
SEK 7.33
7D
2.4%
1Y
41.0%
SynAct Pharma
Market Cap: SEK 1.1b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 19.84
7D
-0.5%
1Y
10.6%
Moberg Pharma
Market Cap: SEK 534.1m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 10.62
7D
-4.2%
1Y
29.4%
AlzeCure Pharma
Market Cap: SEK 885.3m
Operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 6.42
7D
-4.7%
1Y
66.8%